390.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
390.2.0.1 ð Cram Sheet
390.2.0.1.1 ð¥ é« yield 12
- Free hormone biologically active
- GPCR Gαs â cAMP: ACTH/TSH/PTH/LH/FSH/glucagon/β-AR
- GPCR Gαq â Ca²âº/IP3: TRH/GnRH/α1/ADH-V1
- GPCR Gαi â cAMP: somatostatin/α2
- RTK: insulin/IGF-1
- JAK/STAT: GH/PRL/leptin
- Nuclear receptor: steroid/thyroid/VitD/RA
- McCune-Albright: Gαs activating
- Pseudohypoparathyroidism (Albright): Gαs inactivating
- Laron syndrome: GH-R mutation, â IGF-1
- GnRH continuous â suppress (䜿 GnRH agonist æ²»æè·è º CA)
- Cortisol AM peak; GH sleep peak; TSH night peak
390.2.0.2 â é« yield
390.2.0.2.1 Carrier Proteins
| Hormone | Carrier | 圱é¿å çŽ |
|---|---|---|
| Thyroid | TBG/TTR/albumin | Pregnancy/OCP â TBG |
| Cortisol | CBG | Pregnancy/OCP â |
| Sex steroid | SHBG | Liver disease/hyperthyroidism â |
| Vit D | DBP | â |
| IGF-1 | IGFBP-3 | GH dependent |
390.2.0.2.2 Activating vs Inactivating Mutations
| çªè® | åœ±é¿ | ç¯äŸ |
|---|---|---|
| Activating | éåºŠæ¿æŽ» | McCune-Albright (Gαs), familial LH-R, Jansen PTH-R |
| Inactivating | å€±èœ | PHP (Gαs), Laron (GH-R), CAIS (AR), nephrogenic DI (V2R/AQP2) |
390.2.0.3 ð¯ èªææª¢æž¬
- ACTH receptor type? â GPCR Gαs
- Insulin receptor? â RTK
- GH/PRL signaling? â JAK/STAT
- Steroid hormone? â Nuclear receptor
- Free vs total: åªå biologically active? â Free
- Pregnancy å° TBG? â â
- McCune-Albright Gαs which? â Activating mosaic
- PHP Gαs which? â Inactivating
- Laron syndrome? â GH-R loss
- CAIS gene? â AR
- GnRH continuous effect? â Suppress
- Cortisol peak? â æ©æš 6-8 AM
â ïž AI èçš¿ã